These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1703059)

  • 41. [Phenotypic changes in a case of T-ALL].
    Montes MJ; Santos JL; Moreno PM; Gutiérrez F
    Sangre (Barc); 1992 Feb; 37(1):77-8. PubMed ID: 1585243
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparative flow cytometric study of clonal excess in leukaemic peripheral blood from patients suffering from chronic lymphocytic leukaemia (B-CLL) by different antibodies, staining techniques and the effects of blood storage.
    Schmidtke G; Schmucker U; Brittinger G; Höffkes HG
    Clin Lab Haematol; 1999 Apr; 21(2):103-12. PubMed ID: 10342069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow cytometric analysis of T-lymphocyte subpopulations in B-cell chronic lymphocytic leukemia: correlation with clinical stage.
    Hautekeete ML; De Bock RF; Van Bockstaele DR; Colpin GC; Berneman ZN; Peetermans ME
    Blut; 1987 Nov; 55(5):447-52. PubMed ID: 3499946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant determination of phenotypic markers in chronic lymphocytic leukemia (CLL) lymphocytes after cryopreservation.
    Thurgood LA; Lower KM; Macardle C; Kuss BJ
    Exp Hematol; 2018 Jul; 63():28-32.e1. PubMed ID: 29705268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors in stage AO B-cell chronic lymphocytic leukaemia.
    Oscier DG; Stevens J; Hamblin TJ; Pickering RM; Fitchett M
    Br J Haematol; 1990 Nov; 76(3):348-51. PubMed ID: 2261344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. B-cell chronic lymphocytic leukaemia: prognostic value of the immunophenotype and the clinico-haematological features.
    Orfao A; Gonzalez M; San Miguel JF; Rios A; Canizo MC; Hernandez J; Maricato ML; Lopez Borrasca A
    Am J Hematol; 1989 May; 31(1):26-31. PubMed ID: 2705440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytotoxicity of the CD37 antibody BI 836826 against chronic lymphocytic leukaemia cells in combination with chemotherapeutic agents or PI3K inhibitors.
    Krause G; Baki I; Kerwien S; Knödgen E; Neumann L; Göckeritz E; Landwehr T; Heider KH; Hallek M
    Br J Haematol; 2016 Jun; 173(5):791-4. PubMed ID: 26271483
    [No Abstract]   [Full Text] [Related]  

  • 48. Increased percentage of activated T lymphocytes in B cell lymphocytic leukaemia (B-CLL) patients.
    Garcia-Suarez J; Prieto A; Reyes E; Merino JL; Alvarez-Mon M
    Br J Haematol; 1991 Dec; 79(4):657-8. PubMed ID: 1772793
    [No Abstract]   [Full Text] [Related]  

  • 49. Lymphocytes with crystalline inclusions in early chronic lymphocytic leukaemia.
    Green S; Lyall H; Baker R
    Br J Haematol; 2012 Jan; 156(2):154. PubMed ID: 21819391
    [No Abstract]   [Full Text] [Related]  

  • 50. Chronic lymphatic leukaemia: an investigation of HLA antigen frequencies and white cell differential counts in patients, relatives and controls.
    Jones HP; Whittaker JA
    Leuk Res; 1991; 15(7):543-9. PubMed ID: 1907341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of gene expression and flow cytometry for immune profiling in chronic lymphocytic leukaemia.
    Sharpe C; Davis J; Mason K; Tam C; Ritchie D; Koldej R
    J Immunol Methods; 2018 Dec; 463():97-104. PubMed ID: 30267664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leukaemia.
    Michieli M; Raspadori D; Damiani D; Geromin A; Gallizia C; Michelutti A; Fanin R; Fasola G; Russo D; Tazzari P
    Br J Haematol; 1991 Apr; 77(4):460-5. PubMed ID: 1673863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An Analysis of Circulating CD4 Lymphocyte Subpopulations in B-Cell Chronic Lymphocytic Leukaemia.
    Crockard AD; Alexander HD; Stephenson CF; McCrea P; Desai ZR; Morris TC; McNeill TA
    Leuk Lymphoma; 1990; 3(2):127-33. PubMed ID: 27457298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of lymphocyte immunophenotyping in selected diseases.
    Marti GE; Fleisher TA
    Pathol Immunopathol Res; 1988; 7(5):319-37. PubMed ID: 3068665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunophenotypic stability of T-cell large granular lymphocytic leukaemia by flow cytometry.
    Spears MD; Harrington AM; Kroft SH; Olteanu H
    Br J Haematol; 2010 Oct; 151(1):97-9. PubMed ID: 20636433
    [No Abstract]   [Full Text] [Related]  

  • 56. Minimal-change glomerulonephritis and chronic lymphocytic leukaemia.
    Spalding EM; Watkins S; Warwicker P
    Nephron; 2001 Jul; 88(3):283-4. PubMed ID: 11423765
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical importance of T-ALL subclassification according to thymic or prethymic maturation stage.
    Ludwig WD; Thiel E; Bartram CR; Kranz BR; Raghavachar A; Löffler H; Ganser A; Büchner T; Hiddemann W; Heil G
    Haematol Blood Transfus; 1990; 33():419-27. PubMed ID: 2182433
    [No Abstract]   [Full Text] [Related]  

  • 58. Central nervous system involvement in chronic lymphocytic leukemia: uncommon manifestation with undefined therapeutic management.
    Rossi C; Brisou G; Baseggio L; Roch J; Safar V; Karlin L; Sesques P; Bouafia-Sauvy F; Lebras L; Coiffier B; Salles G; Michallet AS
    Leuk Lymphoma; 2014 Aug; 55(8):1939-41. PubMed ID: 24237449
    [No Abstract]   [Full Text] [Related]  

  • 59. Enhanced clearance of leukemic lymphocytes in B-cell chronic lymphocytic leukemia with etodolac.
    Nardella FA; LeFevre JA
    Blood; 2002 Apr; 99(7):2625-6. PubMed ID: 11926185
    [No Abstract]   [Full Text] [Related]  

  • 60. Function of granulocytes in B-chronic lymphatic leukaemia.
    Dekaris D; Handl S; Sabioncello A; Rabatić S
    Blut; 1990 Dec; 61(6):354-7. PubMed ID: 2291983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.